Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coya Therapeutics (COYA) Other Operating Expenses (2022 - 2025)

Coya Therapeutics' Other Operating Expenses history spans 4 years, with the latest figure at -$665997.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 38.14% year-over-year to -$665997.0; the TTM value through Sep 2025 reached -$4.5 million, down 33.41%, while the annual FY2024 figure was -$4.6 million, 9.84% down from the prior year.
  • Other Operating Expenses for Q3 2025 was -$665997.0 at Coya Therapeutics, up from -$1.5 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $390000.0 in Q4 2022 and bottomed at -$1.5 million in Q2 2025.
  • The 4-year median for Other Operating Expenses is -$991941.0 (2024), against an average of -$642198.2.
  • The largest annual shift saw Other Operating Expenses tumbled 613.46% in 2024 before it surged 38.14% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at $390000.0 in 2022, then plummeted by 50.47% to $193186.0 in 2023, then crashed by 613.46% to -$991941.0 in 2024, then surged by 32.86% to -$665997.0 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Other Operating Expenses are -$665997.0 (Q3 2025), -$1.5 million (Q2 2025), and -$1.3 million (Q1 2025).